Lindville Bio is an ATMP consultancy service specializing in the scalable manufacture of Pluripotent Stem Cells (PSC/iPSC) and therapeutic development.
PSC/iPSC-derived therapy transnational journey requires expertise spanning multiple professional silos. Beginning with the patient and final medical product in mind, our approach is to adopt a holistic vision for translation to develop the most efficient and cost-effective route to clinical impact.
Our mission is to enable large scale clinical application of the new generation of PSC/iPSC-derived therapies by helping our clients to tackle current and potential drawbacks in their development and manufacturing processes launching safe, effective and commercially viable products.
We are a focused, knowledgeable, and globally well-networked team that believes in collaboration. As good listeners and team players, we work closely with our clients to understand their needs and provide customized solutions. If we don't have the answers, we know who will.